Novel Foods-authorized UK leader in CBD/THC transdermal patches & 3d-printed pills
Unique, differentiated, revenue driven medical cannabis company specializing in drug-in-adhesive CBD patches and 3D printed pills, offering a significant technology transfer opportunity
Listing ID:
16503339167
Licence(s) Held:
Novel Food Authorisation for Capsules & Oils
Seeking outright divestiture of the brand, going-concern business, transferable technology, optional leased facility, and fixed assets for £1 million
Listing Details:
Branded leading supplier of specialized, niche drug-in-adhesive CBD (and future THC) patches in the UK
Aims to manufacture and build a range of transdermal patches for the over-the-counter CBD and medical cannabis markets
Currently has a fully built, 14,500 ft.² EU-GMP compliant manufacturing facility, fitted as a bespoke laboratory with various sized “clean room” labs
Undertaking labelling, packaging, retail sales, storage and distribution of excellent product mix of CBD Patches, CBD oils, CBD Capsules, CBD Vapes & CBD Cosmetics with future plans to add HC products
Products are sold successfully through the company’s website and through 3rdparty platforms
Strong focus on SEO marketing, brand exposure, customer engagement and subscribers, which has seen customer base grown by >250%
Exclusive worldwide agreement in place with a specialized technology company for the manufacture of unique cannabinoid patches for the medical and over-the-counter markets
Exclusive partnership with 3D printer manufacturer for pills which are then sold to clinics, pharmaceutical wholesalers or sold as CBD products in the OTC market (and future THC market potential)
Experienced leadership team with deep operating experience, marketing, R&D and a proven track record
In the process of applying for Manufacturing Specials License, WDA, Controlled Drug Storage and Human Tissue license
Developing proprietary IP for cannabinoid patch formulations and production
Strategically aligned roadmap, poised for rapid growth through R&D of THC patches and 3D printed pills through key partnerships with API providers
Facility comes with £250,000 of fixed assets
Acquisition includes a successful, interactive, revenue generating magazine focused on fibromyalgia which provides pain management solutions for patients
Seeking outright divestiture of the brand, going-concern business, transferable technology, optional leased facility, and fixed assets
There is an option to purchase the real estate
16503339167